Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Labcyte Issued 26th Patent Describing Reduction of Electrostatic Charge

Labcyte Inc. announces the issuance of U.S. Patent 7,070,260. This patent describes the use of deionization of microplates and reservoirs to ensure improved precision and accuracy of acoustic droplet ejection (ADE) and other techniques employing the transfer of small fluid droplets. Plastic multi-well microplates such as those commonly used in the discovery of drugs by pharmaceutical companies, often become electrostatically charged due to handling.

July 11, 2006

Sunnyvale, CA

Sunnyvale, CA, July 11, 2006 – Labcyte Inc. announces the issuance of U.S. Patent 7,070,260. This patent describes the use of deionization of microplates and reservoirs to ensure improved precision and accuracy of acoustic droplet ejection (ADE) and other techniques employing the transfer of small fluid droplets. Plastic multi-well microplates such as those commonly used in the discovery of drugs by pharmaceutical companies, often become electrostatically charged due to handling. The electrostatic charge present on either the source well or the destination for the droplet may affect the volume and trajectory of the droplet. In particular, when using acoustic ejection of DMSO droplets, a microplate with an uncontrolled electrostatic charge, secondary or satellite droplets are occasionally seen and the volume variation seen in ADE transfers may vary by more than 25%. With the elimination of electrostatic charge on source wells and the droplet destination as described in this patent, volume variation was shown to reduce to 2% with the complete elimination of secondary or satellite droplets.

“This patent describes technology currently employed in the Echo™ 550 and Echo™ 555 liquid handlers,” said Chief Technical Officer, Richard Ellson. “Deionization of both the source microplate and the destination microplates ensures that droplets will fly true and that there will be no cross contamination of wells from samples traveling to incorrect wells or failing to reach the destination and falling back into other wells in the source plate. Important for many users of our instrumentation is the excellent accuracy and precision of the transfer, which has been defined as ‘best-in-class’.”

“We believe that ADE practiced without this patented technology will suffer significantly in quality. Perhaps of greatest concern, when ADE is practiced without deionization, it is possible for the electrostatically charged droplets to travel to incorrect wells leading to cross-contamination and errors in analysis. Our processes complete eliminate that possibility.”

ADE transfers compounds directly from source microplates to destination assay plates where both plate types are composed of conventional well plate polymers that are prone to accumulating electrostatic charges from handling like polypropylene and cyclo-olefin copolymer (COC). Direct transfer eliminates intermediate dilutions and the concomitant loss of compounds by adsorption to tips and well surfaces. Pharmaceutical researchers have proved that these losses can lead to failure to identify potential drugs. Elimination of the consumables associated with intermediate dilutions also results in savings that approximate the cost of the instrument in one year. Labcyte Inc. provides two instruments that use ADE—the Echo 550 liquid handler, which is used in seven of the 10 top pharmaceutical companies as well as at leading academic and research institutions and contract research organizations, and the recently introduced Echo 555, which was designed for UHTS laboratories requiring very high throughput.

Labcyte Inc., headquartered in Sunnyvale, California, provides plastic laboratory supplies, as well as the new Echo 555 liquid handler and the award-winning Echo 550 liquid handler. The Labcyte acoustic liquid handling technology has broad applications in the life science including dispensing equipment, assay systems, particle manufacturing, reagent multispotting for MALDI imaging applications, and living-cell transfer devices. Labcyte has 26 issued U.S. patents, 1 issued European patent and additional international filings. For more information, visit the company’s website, www.labcyte.com.





MAIN CONTACT
LABCYTE INC.
170 Rose Orchard Way
San Jose, California 95134
USA
Tel:
+1 408 747-2000
Toll-free:
+1 877 742-6548
Sales:
+1 877 742-6548, option 1
Fax:
+1 408 747-2010
Contact:
REQUEST INFO

PRESS CONTACT
Nicole Litchfield
Bioscribe, Inc.
Tel:
+1 415 793-6468
Email:
nicole@bioscribe.com
TOP